Literature DB >> 17970078

Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line.

Masahiko Okamura1, Masaki Kobayashi, Fumika Suzuki, Jun Shimada, Hiroshi Sakagami.   

Abstract

The possible apoptosis-inducing activity of several sequential treatments of cisplatin (CDDP) and 5-fluorouracil (5-FU) against the human oral squamous cell carcinoma HSC-2 cell line was investigated. The following three combination treatments (CT) were used: simultaneous treatment with CDDP and 5-FU (for 72 hours) (CT-1), CDDP treatment (24 hours) followed by 5-FU treatment (48 hours) (CT-2) and 5-FU treatment (24 hours) followed by CDDP treatment (48 hours) (CT-3). CT-1 produced the highest cytotoxicity, followed by CT-3 and CT-2. No treatment induced any detectable internucleosomal DNA fragmentation, and caspase-3,-8 and -9 were activated to a much lesser extent than that attained using actinomycin D. High-performance liquid chromatography analysis demonstrated that 5-FU, as well as CT-1 and CT-2, preferentially reduced the intracellular concentration of putrescine. These results suggest that simultaneous treatment with CDDP and 5-FU induces lower level of apoptotic cell death in HSC-2 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970078

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles.

Authors:  Masahiro Sugimoto; David T Wong; Akiyoshi Hirayama; Tomoyoshi Soga; Masaru Tomita
Journal:  Metabolomics       Date:  2009-09-10       Impact factor: 4.290

Review 2.  Metabolomics study of oral cancers.

Authors:  Xun Chen; Dongsheng Yu
Journal:  Metabolomics       Date:  2019-02-08       Impact factor: 4.290

3.  The effect of combination treatment with docosahexaenoic acid and 5-fluorouracil on the mRNA expression of apoptosis-related genes, including the novel gene BCL2L12, in gastric cancer cells.

Authors:  Zhihong Zhuo; Leming Zhang; Qitian Mu; Yanru Lou; Zhaohui Gong; Yijiu Shi; Guifang Ouyang; Yi Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-11-18       Impact factor: 2.416

4.  Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.

Authors:  Ying-Ray Lee; Wei-Ching Wu; Wen-Tsai Ji; Jeff Yi-Fu Chen; Ya-Ping Cheng; Ming-Ko Chiang; Hau-Ren Chen
Journal:  J Biomed Sci       Date:  2012-01-27       Impact factor: 8.410

5.  Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.

Authors:  Kao-Jean Huang; Chin-Ho Kuo; Shu-Hsin Chen; Ching-Yen Lin; Ying-Ray Lee
Journal:  J Cell Mol Med       Date:  2018-01-24       Impact factor: 5.310

6.  Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin.

Authors:  Chen-Hsi Hsieh; Mei-Ling Hou; Meng-Hsuan Chiang; Hung-Chi Tai; Hui-Ju Tien; Li-Ying Wang; Tung-Hu Tsai; Yu-Jen Chen
Journal:  J Transl Med       Date:  2013-09-26       Impact factor: 5.531

7.  Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo.

Authors:  Chih-Chia Yu; Shih-Kai Hung; Hon-Yi Lin; Wen-Yen Chiou; Moon-Sing Lee; Hui-Fen Liao; Hsien-Bin Huang; Hsu-Chueh Ho; Yu-Chieh Su
Journal:  Oncotarget       Date:  2017-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.